Clinical trial
Starting Technology in At Risk Type 1 Diabetes (STAR-T1D) Study
NCT06453928 is registered in ClinicalTrials.gov with University of California, Los Angeles as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Starting Technology in At Risk Type 1 Diabetes (STAR-T1D) Study
- Lead sponsor
- University of California, Los Angeles
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- September 5, 2024
- Completion date
- June 1, 2027
- Enrollment
- 40 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.